“When she was unable to find funding, Penn demoted her, taking her off the track to full professorship.”
Penn cut Katalin Karikó’s salary and pushed her off the tenure track because mRNA couldn’t win grants. Penn still held the patents. Now her work is in the vaccines going into arms, and BioNTech is the one that made her a VP. Universities fund what is fashionable and claim credit for what works.